Provided by Tiger Fintech (Singapore) Pte. Ltd.

OncoCyte Corporation

2.79
+0.19007.31%
Post-market: 2.800.0100+0.36%18:10 EDT
Volume:35.45K
Turnover:97.01K
Market Cap:79.79M
PE:-0.62
High:2.86
Open:2.60
Low:2.60
Close:2.60
Loading ...
Mar 05, 2021

Voluntary Delisting

25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 22, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 05, 2021

Major Issues Report

8-K - Current report
Feb 04, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Major Issues Report

8-K - Current report
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 28, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 22, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 21, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 16, 2020

Major Issues Report

8-K - Current report
Nov 30, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Sep 28, 2020

Major Issues Report

8-K - Current report